They would easily pay 5-10c when they would be convinced that the MC could reach $500m when both, GBM and AML get their rego trials approved by the FDA and that when they get FDA drug approval the MC will reach the $billion range.
Assuming 1.7b shares on issue after those 800m, the sp would be at 25-30c and then reach the $ range. That is what the chair needs to present after the COO / CMO has presented the incredible science and the peer comparison. I would achieve exactly that having those data as back up. But it takes to be present at those presentations and show the fighting spirit. If you want to sell a Ferrari you can't sell it the dull way like selling a Fiat 500.
Steini, you are arrogant, nobody could sell it that way. Really? If ALA can sell NOTHING for a lot, I can sell a LOT for a decent amount.
That's why I have started contacting top 20 holders to put pressure on Hopper. If we want things to improve we have to start somewhere. Just complaining on HC won't change anything.
GLTA
- Forums
- ASX - By Stock
- CHM
- Ann: Notice of Extraordinary General Meeting/Proxy Form
Ann: Notice of Extraordinary General Meeting/Proxy Form, page-125
-
- There are more pages in this discussion • 160 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CHM (ASX) Chart |
Day chart unavailable